Physician profile
Brian Chen
NPI 1780176701
$18,351.88
in general payments reported to CMS, 2019-2025
6 companies · $6,666 in 2025
The $6,666 reported for 2025 was more than what 90% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.92 · 2022: $301 · 2023: $1,410 · 2024: $9,963 · 2025: $6,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,175 · Food and Beverage: $4,021 · Honoraria: $4,000 · Travel and Lodging: $3,418 · Education: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,175.00 |
| Food and Beverage | $4,020.57 |
| Honoraria | $4,000.00 |
| Travel and Lodging | $3,418.14 |
| Education | $424.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15,890.90 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $895.98 | 2021-2025 | |
| Harmony Biosciences LLC | $803.97 | 2022-2025 | Wakix |
| Noctrix Health, INC. | $375.93 | 2024-2025 | Nidra |
| Avadel Cns Pharmaceuticals, LLC | $217.36 | 2024-2025 | Lumryz |
| Acumed LLC | $167.74 | 2025 | Acumed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.